Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Aug 01, 2006 (Vol. 26, No. 14)

NewsBlip.net—Quality News Groups

URL:newsblip.net
  • Great idea, well implemented
  • None
In the early days of the Internet, I spent a large amount of time trolling the various UseNet newsgroups. After a while, these became unwieldy, and though they didn’t go away, I did—at least until I discovered an eclectic collection of newsgroups on NewsBlip.net. Providing access to a selected subset of the zillions of UseNet groups, NewsBlip wins my vote for increasing the signal and reducing the noise. The site describes their approach best—"We carry only hand-picked newsgroups with real discussions, and we monitor the overall quality of our newsgroups to ensure that we don’t carry clunkers." I couldn’t agree more with them. Topic areas include Computers/Internet, Health/Medicine, Home/Family, News, Science/Technology, Recreation/Entertainment, and Society/Culture. Registration is required for full site access, but you can see a lot without it.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »